Kevin Paul Foley

Person

Landsdale, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Triazole compounds that modulate Hsp90 activity
- Patent number 9,206,162
- Issue date Dec 8, 2015
- Synta Pharmaceuticals Corp.
- Lijun Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cancer therapy using a combination of a Hsp90 inhibitory compounds...
- Patent number 9,205,086
- Issue date Dec 8, 2015
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole compounds that modulate HSP90 activity
- Patent number 9,156,794
- Issue date Oct 13, 2015
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating proliferative disorders associated with mutatio...
- Patent number 9,108,933
- Issue date Aug 18, 2015
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating non-Hodgkin's lymphoma
- Patent number 9,101,614
- Issue date Aug 11, 2015
- Synta Pharmaceuticals Corp.
- Kevin Foley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of proliferative disorders
- Patent number 9,090,603
- Issue date Jul 28, 2015
- Synta Pharmaceuticals Corporation
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazone compounds that modulate HSP90 activity
- Patent number 9,090,569
- Issue date Jul 28, 2015
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 9,006,277
- Issue date Apr 14, 2015
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating a B-raf associated cancer with an Hsp90 inhibitor
- Patent number 8,969,396
- Issue date Mar 3, 2015
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,927,548
- Issue date Jan 6, 2015
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole compounds that modulate HSP90 activity
- Patent number 8,921,407
- Issue date Dec 30, 2014
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds that modulate Hsp90 activity
- Patent number 8,901,308
- Issue date Dec 2, 2014
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,835,464
- Issue date Sep 16, 2014
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating proliferative disorders associated with mutatio...
- Patent number 8,648,104
- Issue date Feb 11, 2014
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole compounds that modulate HSP90 activity
- Patent number 8,629,285
- Issue date Jan 14, 2014
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of proliferative disorders
- Patent number 8,598,366
- Issue date Dec 3, 2013
- Synta Pharmaceuticals Corporation
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazinone and diazinone derivatives useful as HSP90 inhibitors
- Patent number 8,524,712
- Issue date Sep 3, 2013
- Synta Pharmaceuticals Corp.
- Chi-Wan Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,415,377
- Issue date Apr 9, 2013
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,362,055
- Issue date Jan 29, 2013
- Synta Pharmaceuticals, Inc.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazole compounds that modulate HSP90 activity
- Patent number 8,329,899
- Issue date Dec 11, 2012
- Synta Pharmaceuticals, Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,329,736
- Issue date Dec 11, 2012
- Synta Pharmaceuticals, Corp.
- Dinesh U. Chimmanamada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,318,790
- Issue date Nov 27, 2012
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of proliferative disorders
- Patent number 8,269,017
- Issue date Sep 18, 2012
- Synta Pharmaceuticals Corporation
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,188,075
- Issue date May 29, 2012
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate HSP90 activity
- Patent number 8,183,384
- Issue date May 22, 2012
- Synta Pharmaceuticals Corp.
- Dinesh U. Chimmanamada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating non-Hodgkin's lymphoma
- Patent number 8,063,083
- Issue date Nov 22, 2011
- Synta Pharmaceuticals Corp.
- Kevin Foley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate Hsp90 activity
- Patent number 8,053,456
- Issue date Nov 8, 2011
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating proliferative disorders with HSP90 inhibitors
- Patent number 8,034,834
- Issue date Oct 11, 2011
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of proliferative disorders
- Patent number 7,884,094
- Issue date Feb 8, 2011
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole compounds that modulate Hsp90 activity
- Patent number 7,825,148
- Issue date Nov 2, 2010
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20240124460
- Publication date Apr 18, 2024
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS(G12D)
- Publication number 20240116950
- Publication date Apr 11, 2024
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20230391772
- Publication date Dec 7, 2023
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20230391792
- Publication date Dec 7, 2023
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS(G12D)
- Publication number 20230365595
- Publication date Nov 16, 2023
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20220168427
- Publication date Jun 2, 2022
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20220162228
- Publication date May 26, 2022
- Ranok Therapeutics (Hangzhou) Co. Ltd.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...
- Publication number 20160120849
- Publication date May 5, 2016
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20160000756
- Publication date Jan 7, 2016
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20150266858
- Publication date Sep 24, 2015
- Synta Pharmaceuticals Corp.
- Lijun Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20150183771
- Publication date Jul 2, 2015
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING B CELL REGULATED AUTOIMMUNE DISORDERS
- Publication number 20150174132
- Publication date Jun 25, 2015
- Synta Pharmaceuticals Corporation
- Kevin Foley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Treating Proliferative Disorders Associated with Protoon...
- Publication number 20150094349
- Publication date Apr 2, 2015
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20140371222
- Publication date Dec 18, 2014
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING PROLIFERATIVE DISORDERS ASSOCIATED WITH MUTATIO...
- Publication number 20140221375
- Publication date Aug 7, 2014
- Synta Pharmaceuticals Corp.
- Zhenjian Du
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20140094436
- Publication date Apr 3, 2014
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH RADIOTHERAPY
- Publication number 20140051664
- Publication date Feb 20, 2014
- Synta Pharmaceuticals Corp.
- Kevin P. Foley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSP90 INHIBITORY COMPOUNDS IN TREATING JAK/STAT SIGNALING-MEDIATED...
- Publication number 20140045908
- Publication date Feb 13, 2014
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
- Publication number 20140045795
- Publication date Feb 13, 2014
- Synta Pharmaceuticals Corporation
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZINONE AND DIAZINONE DERIVATIVES USEFUL AS HSP90 INHIBITORS
- Publication number 20130345219
- Publication date Dec 26, 2013
- Synta Pharmaceuticals Corp.
- Chi-Wan Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20130296378
- Publication date Nov 7, 2013
- Synta Pharmaceuticals Corp.
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND A...
- Publication number 20130171105
- Publication date Jul 4, 2013
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...
- Publication number 20130156755
- Publication date Jun 20, 2013
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...
- Publication number 20130150385
- Publication date Jun 13, 2013
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20130072461
- Publication date Mar 21, 2013
- Synta Pharmaceuticals Corp.
- Dinesh U. Chimmanamada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20130072536
- Publication date Mar 21, 2013
- Synta Pharmaceuticals Corp.
- Weiwen Ying
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20120330009
- Publication date Dec 27, 2012
- Weiwen Ying
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
- Publication number 20120289483
- Publication date Nov 15, 2012
- Synta Pharmaceuticals Corporation
- Lijun Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS
- Publication number 20120245186
- Publication date Sep 27, 2012
- Synta Pharmaceuticals Corp.
- Ronald K. Blackman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
- Publication number 20120202813
- Publication date Aug 9, 2012
- Synta Pharmaceuticals Corp.
- Dinesh U. Chimmanamada
- C07 - ORGANIC CHEMISTRY

Kevin Paul Foley

Person

Patents Grantslast 30 patents

Triazole compounds that modulate Hsp90 activity

Cancer therapy using a combination of a Hsp90 inhibitory compounds...

Imidazole compounds that modulate HSP90 activity

Method for treating proliferative disorders associated with mutatio...

Method for treating non-Hodgkin's lymphoma

Compounds for the treatment of proliferative disorders

Triazone compounds that modulate HSP90 activity

Triazole compounds that modulate HSP90 activity

Method for treating a B-raf associated cancer with an Hsp90 inhibitor

Triazole compounds that modulate HSP90 activity

Pyrazole compounds that modulate HSP90 activity

Triazole compounds that modulate Hsp90 activity

Triazole compounds that modulate HSP90 activity

Method for treating proliferative disorders associated with mutatio...

Imidazole compounds that modulate HSP90 activity

Compounds for the treatment of proliferative disorders

Triazinone and diazinone derivatives useful as HSP90 inhibitors

Triazole compounds that modulate HSP90 activity

Triazole compounds that modulate HSP90 activity

Pyrazole compounds that modulate HSP90 activity

Triazole compounds that modulate HSP90 activity

Triazole compounds that modulate HSP90 activity

Compounds for the treatment of proliferative disorders

Triazole compounds that modulate HSP90 activity

Triazole compounds that modulate HSP90 activity

Method for treating non-Hodgkin's lymphoma

Triazole compounds that modulate Hsp90 activity

Method for treating proliferative disorders with HSP90 inhibitors

Compounds for the treatment of proliferative disorders

Triazole compounds that modulate Hsp90 activity

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

INHIBITORS OF KRAS(G12D)

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

INHIBITORS OF KRAS(G12D)

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...

IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

METHOD FOR TREATING B CELL REGULATED AUTOIMMUNE DISORDERS

Method for Treating Proliferative Disorders Associated with Protoon...

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

METHOD FOR TREATING PROLIFERATIVE DISORDERS ASSOCIATED WITH MUTATIO...

IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH RADIOTHERAPY

HSP90 INHIBITORY COMPOUNDS IN TREATING JAK/STAT SIGNALING-MEDIATED...

COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

TRIAZINONE AND DIAZINONE DERIVATIVES USEFUL AS HSP90 INHIBITORS

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND A...

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS...

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

PYRAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

COMBINATION CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY